US 11,939,344 B2
Spirocyclic compounds
James Michael Smith, Cambridge (GB)
Assigned to AstraZeneca AB, Sodertalje (SE)
Filed by ASTRAZENECA AB, Sodertalje (SE)
Filed on Jun. 15, 2023, as Appl. No. 18/335,225.
Application 18/335,225 is a continuation of application No. 18/306,596, filed on Apr. 25, 2023, abandoned.
Application 18/306,596 is a continuation of application No. PCT/EP2022/075248, filed on Sep. 12, 2022.
Claims priority of provisional application 63/243,267, filed on Sep. 13, 2021.
Prior Publication US 2023/0357279 A1, Nov. 9, 2023
Int. Cl. C07D 519/00 (2006.01)
CPC C07D 519/00 (2013.01) 4 Claims
 
1. A compound which is (S)-2-((5-Amino-6-fluoro-1H-pyrrolo[3,2-b]pyridin-2-yl)methyl)-1′-(but-2-yn-1-yl)-5-fluorospiro[isoindoline-1,3′-pyrrolidine]-2′,3-dione:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.